subscribe
 

AMS

CRISPR/Cas9 knockout cell lines

AMS Bio has established a comprehensive portfolio of knock-out cell lines and lysates generated with CRISPR/Cas9 technology



New substrates for nanotechnology

Noble metal coated substrates for nanotechnology applications are now available from AMS Bio to assist researchers in characterising self-assembled monolayers



Experimental cell lines introduced

Experimental cell lines help screening for CAR T therapies - AMS Bio has added new experimental cell lines to its CAR T cell research range.



New biology and oncology products

AMS Bio has expanded its Wnt signalling pathway product portfolio to assist researchers in two key fields: biology and oncology



New protein expression system launched

High yield eukaryotic cell-free protein expression system is latest launch from AMS Bio



Induced pluripotent stem cells expertise

Expert on induced pluripotent stem cells for regenerative research to give talks in UK in December



Consistent high quality cell line controls

Expansion to range of high quality FFPE cancer cell line controls for immunohistochemistry (IHC), in situ hybridisation (ISH) and next generation sequencing (NGS) applications



Circulating tumour DNA reference standards

AMS Bio announce the launch of a new range of circulating tumour DNA (ctDNA) reference standards for cancer disease management research



Subscribe

Subscribe



Newsbrief

FREE NEWSBRIEF SUBSCRIPTION

To receive the Scientist Live weekly email NewsBrief please enter your details below

Twitter Icon © Setform Limited
subscribe